|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM266221009 |
003 |
DE-627 |
005 |
20231224214023.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2017 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2016.11.001
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0887.xml
|
035 |
|
|
|a (DE-627)NLM266221009
|
035 |
|
|
|a (NLM)27847316
|
035 |
|
|
|a (PII)S1521-6616(16)30111-5
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Berker, Moritz
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Allergies - A T cells perspective in the era beyond the TH1/TH2 paradigm
|
264 |
|
1 |
|c 2017
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 13.06.2017
|
500 |
|
|
|a Date Revised 18.03.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2016 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Allergic diseases have emerged as a major health care burden, especially in the western hemisphere. They are defined by overshooting reactions of an aberrant immune system to harmless exogenous stimuli. The TH1/TH2 paradigm assumes that a dominance of TH2 cell activation and an inadequate TH1 cell response are responsible for the development of allergies. However, the characterization of additional T helper cell subpopulations such as TH9, TH17, TH22, THGM-CSF and their interplay with regulatory T cells suggest further layers of complexity. This review summarizes state-of-the-art knowledge on T cell diversity and their induction, while revisiting the TH1/TH2 paradigm. With respect to these numerous contributors, it offers a new perspective on the pathogenesis of asthma, allergic rhinitis (AR) and atopic dermatitis (AD) incorporating recent discoveries in the field of T cell plasticity
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Review
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a IL9 protein, human
|2 NLM
|
650 |
|
7 |
|a Interleukin-9
|2 NLM
|
650 |
|
7 |
|a Granulocyte-Macrophage Colony-Stimulating Factor
|2 NLM
|
650 |
|
7 |
|a 83869-56-1
|2 NLM
|
700 |
1 |
|
|a Frank, Larissa Johanna
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Geßner, Anja Lidwina
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Grassl, Niklas
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Holtermann, Anne Verena
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Höppner, Stefanie
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kraef, Christian
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Leclaire, Martin Dominik
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Maier, Pia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Messerer, David Alexander Christian
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Möhrmann, Lino
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Nieke, Jan Philipp
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Schoch, Diana
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Soll, Dominik
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Woopen, Christina Marianne Paulina
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 174(2017) vom: 01. Jan., Seite 73-83
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:174
|g year:2017
|g day:01
|g month:01
|g pages:73-83
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2016.11.001
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 174
|j 2017
|b 01
|c 01
|h 73-83
|